Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Crizotinib in MET deregulated or ROS1 rearranged pretreated non-small-cell lung cancer (METROS): a phase II, prospective, multicentre, two-arms trial.

Landi L, Chiari R, Tiseo M, D'Incà F, Dazzi C, Chella A, Delmonte A, Bonanno L, Giannarelli D, Cortinovis DL, De Marinis F, Borra G, Morabito A, Gridelli C, Galetta D, Barbieri F, Grossi F, Capelletto E, Minuti G, Mazzoni F, Verusio C, Bria E, Alì G, Bruno R, Proietti A, Fontanini G, Crinò L, Cappuzzo F.

Clin Cancer Res. 2019 Aug 15. pii: clincanres.0994.2019. doi: 10.1158/1078-0432.CCR-19-0994. [Epub ahead of print]

PMID:
31416808
2.

β-Glucan improves wound healing in silver catfish (Rhamdia quelen).

Dos Santos Voloski AP, de Figueiredo Soveral L, Dazzi CC, Sutili F, Frandoloso R, Kreutz LC.

Fish Shellfish Immunol. 2019 Oct;93:575-579. doi: 10.1016/j.fsi.2019.08.010. Epub 2019 Aug 6.

PMID:
31398396
3.

[Activity and efficacy of vinflunine in third line in patients with advanced urothelial carcinoma of the renal pelvis, progressing to immunotherapy.]

Gamboni A, Casanova C, Salerno V, Dazzi C.

Recenti Prog Med. 2018 Nov;109(11):547-550. doi: 10.1701/3031.30292. Italian.

PMID:
30565574
4.

Frequency of actionable alterations in epidermal growth factor receptor (EGFR) wild type non-small cell lung cancer: experience of the Wide Catchment Area of Romagna (AVR).

Chiadini E, Canale M, Delmonte A, Dazzi C, Casanova C, Capelli L, Mariotti M, Papi M, Gamboni A, Puccetti M, Bravaccini S, Dubini A, Calistri D, Crinò L, Ulivi P.

J Thorac Dis. 2018 Aug;10(8):4858-4864. doi: 10.21037/jtd.2018.07.22.

5.

The amino acid selected for generating mutant TbpB antigens defective in binding transferrin can compromise the in vivo protective capacity.

Guizzo JA, Chaudhuri S, Prigol SR, Yu RH, Dazzi CC, Balbinott N, Frandoloso GP, Kreutz LC, Frandoloso R, Schryvers AB.

Sci Rep. 2018 May 9;8(1):7372. doi: 10.1038/s41598-018-25685-1.

6.

The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power.

Franceschi E, Tosoni A, Minichillo S, Depenni R, Paccapelo A, Bartolini S, Michiara M, Pavesi G, Urbini B, Crisi G, Cavallo MA, Tosatto L, Dazzi C, Biasini C, Pasini G, Balestrini D, Zanelli F, Ramponi V, Fioravanti A, Giombelli E, De Biase D, Baruzzi A, Brandes AA; PERNO Study Group.

World Neurosurg. 2018 Apr;112:e342-e347. doi: 10.1016/j.wneu.2018.01.045. Epub 2018 Jan 11.

PMID:
29337169
7.

Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.

Franceschi E, Depenni R, Paccapelo A, Ermani M, Faedi M, Sturiale C, Michiara M, Servadei F, Pavesi G, Urbini B, Pisanello A, Crisi G, Cavallo MA, Dazzi C, Biasini C, Bertolini F, Mucciarini C, Pasini G, Baruzzi A, Brandes AA; PERNO Study Group.

J Neurooncol. 2018 Jan;136(1):221-222. doi: 10.1007/s11060-017-2638-y.

PMID:
29124650
8.

Prolonged Pemetrexed Infusion Plus Gemcitabine in Refractory Metastatic Colorectal Cancer: Preclinical Rationale and Phase II Study Results.

Passardi A, Fanini F, Turci L, Foca F, Rosetti P, Ruscelli S, Casadei Gardini A, Valgiusti M, Dazzi C, Marangolo M.

Oncologist. 2017 Aug;22(8):886-e79. doi: 10.1634/theoncologist.2017-0206. Epub 2017 Jun 7.

9.

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial.

Tiseo M, Boni L, Ambrosio F, Camerini A, Baldini E, Cinieri S, Brighenti M, Zanelli F, Defraia E, Chiari R, Dazzi C, Tibaldi C, Turolla GM, D'Alessandro V, Zilembo N, Trolese AR, Grossi F, Riccardi F, Ardizzoni A.

J Clin Oncol. 2017 Apr 20;35(12):1281-1287. doi: 10.1200/JCO.2016.69.4844. Epub 2017 Jan 30.

PMID:
28135143
10.

Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors.

Canale M, Petracci E, Delmonte A, Chiadini E, Dazzi C, Papi M, Capelli L, Casanova C, De Luigi N, Mariotti M, Gamboni A, Chiari R, Bennati C, Calistri D, Ludovini V, Crinò L, Amadori D, Ulivi P.

Clin Cancer Res. 2017 May 1;23(9):2195-2202. doi: 10.1158/1078-0432.CCR-16-0966. Epub 2016 Oct 25.

11.

Compartmentalization of gypsum and halite associated with cyanobacteria in saline soil crusts.

Canfora L, Vendramin E, Vittori Antisari L, Lo Papa G, Dazzi C, Benedetti A, Iavazzo P, Adamo P, Jungblut AD, Pinzari F.

FEMS Microbiol Ecol. 2016 Jun;92(6):fiw080. doi: 10.1093/femsec/fiw080. Epub 2016 Apr 17.

PMID:
27090760
12.

Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study.

Franceschi E, Depenni R, Paccapelo A, Ermani M, Faedi M, Sturiale C, Michiara M, Servadei F, Pavesi G, Urbini B, Pisanello A, Crisi G, Cavallo MA, Dazzi C, Biasini C, Bertolini F, Mucciarini C, Pasini G, Baruzzi A, Brandes AA; PERNO Study Group.

J Neurooncol. 2016 May;128(1):157-162. doi: 10.1007/s11060-016-2093-1. Epub 2016 Mar 4. Erratum in: J Neurooncol. 2018 Jan;136(1):221-222.

PMID:
26943851
13.

Nonsquamous, Non-Small-Cell Lung Cancer Patients Who Carry a Double Mutation of EGFR, EML4-ALK or KRAS: Frequency, Clinical-Pathological Characteristics, and Response to Therapy.

Ulivi P, Chiadini E, Dazzi C, Dubini A, Costantini M, Medri L, Puccetti M, Capelli L, Calistri D, Verlicchi A, Gamboni A, Papi M, Mariotti M, De Luigi N, Scarpi E, Bravaccini S, Turolla GM, Amadori D, Crinò L, Delmonte A.

Clin Lung Cancer. 2016 Sep;17(5):384-390. doi: 10.1016/j.cllc.2015.11.004. Epub 2015 Dec 1.

PMID:
26712101
14.

Adrenal incidentalomas and subclinical Cushing syndrome: indications to surgery and results in a series of 26 laparoscopic adrenalectomies.

Pisano G, Calò PG, Erdas E, Pigliaru F, Piras S, Sanna S, Manca A, Dazzi C, Nicolosi A.

Ann Ital Chir. 2015;86:406-12.

PMID:
26567723
15.

Prognostic Evaluation of Disease Outcome in Solid Tumors Investigated With 64Cu-ATSM PET/CT.

Lopci E, Grassi I, Rubello D, Colletti PM, Cambioli S, Gamboni A, Salvi F, Cicoria G, Lodi F, Dazzi C, Mattioli S, Fanti S.

Clin Nucl Med. 2016 Feb;41(2):e87-92. doi: 10.1097/RLU.0000000000001017.

PMID:
26447388
16.

Parents' perception of children's fear: from FSSC-IT to FSSC-PP.

Salcuni S, Dazzi C, Mannarini S, Di Riso D, Delvecchio E.

Front Psychol. 2015 Aug 12;6:1199. doi: 10.3389/fpsyg.2015.01199. eCollection 2015.

17.

Benefit of eribulin in a patient with HER2(+) breast cancer who progressed after trastuzumab and lapatinib: a case report.

Casanova C, Verlicchi A, Mazza V, Dazzi C.

Future Oncol. 2015;11(15 Suppl):9-15. doi: 10.2217/fon.15.147.

PMID:
26235259
18.

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

Brandes AA, Franceschi E, Ermani M, Tosoni A, Albani F, Depenni R, Faedi M, Pisanello A, Crisi G, Urbini B, Dazzi C, Cavanna L, Mucciarini C, Pasini G, Bartolini S, Marucci G, Morandi L, Zunarelli E, Cerasoli S, Gardini G, Lanza G, Silini EM, Cavuto S, Baruzzi A, Baruzzi A, Albani F, Calbucci F, D'Alessandro R, Michelucci R, Brandes A, Eusebi V, Ceruti S, Fainardi E, Tamarozzi R, Emiliani E, Cavallo M, Franceschi E, Tosoni A, Cavallo M, Fiorica F, Valentini A, Depenni R, Mucciarini C, Crisi G, Sasso E, Biasini C, Cavanna L, Guidetti D, Marcello N, Pisanello A, Cremonini AM, Guiducci G, de Pasqua S, Testoni S, Agati R, Ambrosetto G, Bacci A, Baldin E, Baldrati A, Barbieri E, Bartolini S, Bellavista E, Bisulli F, Bonora E, Bunkheila F, Carelli V, Crisci M, Dall'Occa P, de Biase D, Ferro S, Franceschi C, Frezza G, Grasso V, Leonardi M, Marucci G, Mazzocchi V, Morandi L, Mostacci B, Palandri G, Pasini E, Pastore Trossello M, Pession A, Ragazzi M, Riguzzi P, Rinaldi R, Rizzi S, Romeo G, Spagnolli F, Tinuper P, Trocino C, Cerasoli S, Dall'Agata M, Faedi M, Frattarelli M, Gentili G, Giovannini A, Iorio P, Pasquini U, Galletti G, Guidi C, Neri W, Patuelli A, Strumia S, Casmiro M, Gamboni A, Rasi F, Cruciani G, Cenni P, Dazzi C, Guidi A, Zumaglini F, Amadori A, Pasini G, Pasquinelli M, Pasquini E, Polselli A, Ravasio A, Viti B, Sintini M, Ariatti A, Bertolini F, Bigliardi G, Carpeggiani P, Cavalleri F, Meletti S, Nichelli P, Pettorelli E, Pinna G, Zunarelli E, Artioli F, Bernardini I, Costa M, Greco G, Guerzoni R, Stucchi C, Iaccarino C, Rizzi R, Zuccoli G, Api P, Cartei F, Fallica E, Granieri E, Latini F, Lelli G, Monetti C, Ramponi V, Saletti A, Schivalocchi R, Seraceni S, Tola MR, Urbini B, Giorgi C, Montanari E, Cerasti D, Crafa P, Dascola I, Florindo I, Mazza S, Servadei F, Silini E, Torelli P, Immovilli P, Morelli N, Vanzo C.

Neurooncol Pract. 2014 Dec;1(4):166-171. Epub 2014 Aug 28.

19.

Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?

Ulivi P, Delmonte A, Chiadini E, Calistri D, Papi M, Mariotti M, Verlicchi A, Ragazzini A, Capelli L, Gamboni A, Puccetti M, Dubini A, Burgio MA, Casanova C, Crinò L, Amadori D, Dazzi C.

Int J Mol Sci. 2014 Dec 31;16(1):747-57. doi: 10.3390/ijms16010747.

20.

Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial.

Tiseo M, Boni L, Ambrosio F, Camerini A, Vitale MG, Baldini E, Cinieri S, Zanelli F, Defraia E, Passalacqua R, Crino L, Dazzi C, Tibaldi C, Turolla GM, D'Alessandro V, Zilembo N, Riccardi F, Ardizzoni A; Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC).

Clin Lung Cancer. 2015 Jan;16(1):67-70. doi: 10.1016/j.cllc.2014.09.001. Epub 2014 Sep 28.

PMID:
25450879
21.

Salinity and bacterial diversity: to what extent does the concentration of salt affect the bacterial community in a saline soil?

Canfora L, Bacci G, Pinzari F, Lo Papa G, Dazzi C, Benedetti A.

PLoS One. 2014 Sep 4;9(9):e106662. doi: 10.1371/journal.pone.0106662. eCollection 2014. Erratum in: PLoS One. 2014;9(11):e114658.

22.

The Pan European Emesis Registry (PEER): a critical appraisal of the Italian experience.

Pastorelli D, Locatelli MA, Melotti B, Pisano C, Turano S, Mellino U, Provinciali N, Marchetti P, Dazzi C, Berretta M, Giordano A, Lorusso V.

J Chemother. 2013 Oct;25(5):309-17. doi: 10.1179/1973947813Y.0000000118.

PMID:
24070139
23.

Incidence and risk factors for trocar site hernia following laparoscopic cholecystectomy: a long-term follow-up study.

Erdas E, Dazzi C, Secchi F, Aresu S, Pitzalis A, Barbarossa M, Garau A, Murgia A, Contu P, Licheri S, Pomata M, Farina G.

Hernia. 2012 Aug;16(4):431-7. doi: 10.1007/s10029-012-0929-y. Epub 2012 Jun 20.

PMID:
22714582
24.

Gemcitabine and paclitaxel combination as second-line chemotherapy in patients with small-cell lung cancer: a phase II study.

Dazzi C, Cariello A, Casanova C, Verlicchi A, Montanari M, Papiani G, Freier E, Mazza V, Milandri C, Gamboni A, Papi M, Leoni M, Cruciani G, Vertogen B.

Clin Lung Cancer. 2013 Jan;14(1):28-33. doi: 10.1016/j.cllc.2012.03.003. Epub 2012 Apr 25.

PMID:
22537509
25.

Risk of classic Kaposi sarcoma with exposures to plants and soils in Sicily.

Goedert JJ, Calamusa G, Dazzi C, Perna A, Pelser C, Anderson LA, Madsen C, Preiss LR, Airola M, Graubard BI, Messina A, Lauria C, Romano N.

Infect Agent Cancer. 2010 Dec 2;5(1):23. doi: 10.1186/1750-9378-5-23.

26.

Psychological factors involved in prurigo nodularis: A pilot study.

Dazzi C, Erma D, Piccinno R, Veraldi S, Caccialanza M.

J Dermatolog Treat. 2011 Aug;22(4):211-4. doi: 10.3109/09546631003674321. Epub 2010 Jul 28.

PMID:
20666670
27.

Graphology and personality: an empirical study on validity of handwriting analysis.

Dazzi C, Pedrabissi L.

Psychol Rep. 2009 Dec;105(3 Pt 2):1255-68.

PMID:
20229925
28.

Risk of classic Kaposi sarcoma with residential exposure to volcanic and related soils in Sicily.

Pelser C, Dazzi C, Graubard BI, Lauria C, Vitale F, Goedert JJ.

Ann Epidemiol. 2009 Aug;19(8):597-601. doi: 10.1016/j.annepidem.2009.04.002.

29.

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer.

Passardi A, Cecconetto L, Dall'agata M, Dazzi C, Pasquini E, Oliverio G, Zumaglini F, Zoli W, Nanni O, Milandri C, Frassineti GL, Amadori D.

J Transl Med. 2008 Oct 31;6:65. doi: 10.1186/1479-5876-6-65.

30.

Surgical gastrostomy when percutaneous endoscopic gastrostomy is not feasible: indications, results and comparison between the two procedures.

Pisano G, Calò PG, Tatti A, Farris S, Erdas E, Licheri S, Dazzi C, Daniele GM.

Chir Ital. 2008 Mar-Apr;60(2):261-6.

PMID:
18689176
31.

Uncommon pathologies discovered during exploratory laparoscopy for malignant diseases.

Pisano G, Erdas E, Licheri S, Dazzi C, Pomata M, Daniele GM.

Chir Ital. 2007 Nov-Dec;59(6):793-9.

PMID:
18360984
32.

A randomized study comparing filgrastim versus lenograstim versus molgramostim plus chemotherapy for peripheral blood progenitor cell mobilization.

Kopf B, De Giorgi U, Vertogen B, Monti G, Molinari A, Turci D, Dazzi C, Leoni M, Tienghi A, Cariello A, Argnani M, Frassineti L, Scarpi E, Rosti G, Marangolo M.

Bone Marrow Transplant. 2006 Sep;38(6):407-12.

PMID:
16951690
33.

Operative cholangiography during laparoscopic cholecystectomy: considerations about routine or selective policy.

Pisano G, Licheri S, Dazzi C, Erdas E, Pomata M, Daniele GM.

G Chir. 2005 Aug-Sep;26(8-9):333-7.

PMID:
16329778
34.

[Intestinal obstruction due to perforated cecal volvulus. Case report].

Pomata M, Dazzi C, Crobu F, Martinasco L, Pisano G, Licheri S.

G Chir. 2004 Jun-Jul;25(6-7):220-3. Italian.

PMID:
15558982
35.

High-dose chemotherapy for breast cancer.

Dazzi C, Cariello A.

N Engl J Med. 2003 Oct 9;349(15):1476-9; author reply 1476-9. No abstract available.

PMID:
14535260
36.

[Lymph node biopsy in the study of lymphomas: from the incisional biopsy to videolaparoscopic lymphadenectomy].

Pisano G, Licheri S, Dazzi C, Erdas E, Martinasco L, Pomata M, Daniele GM.

Tumori. 2003 Jul-Aug;89(4 Suppl):282-5. Italian.

PMID:
12903622
37.

Prevention and therapy of neutropenia in elderly patients.

Rosti G, Kopf B, Cariello A, Monti M, Dazzi C, Papiani G, Giovanis P, De Giorgi U, Marangolo M.

Crit Rev Oncol Hematol. 2003 Jun;46(3):247-53. Review.

PMID:
12791424
38.

A high cytosol value of urokinase-type plasminogen activator (uPA) may be predictive of early relapse in primary breast cancer.

Dazzi C, Cariello A, Maioli P, Magi S, Rosti G, Giovanis P, Giovannini G, Lanzanova G, Marangolo M.

Cancer Invest. 2003 Apr;21(2):208-16.

PMID:
12743986
40.

High-dose chemotherapy for solid tumors: results of the EBMT.

Rosti G, Ferrante P, Ledermann J, Leyvraz S, Ladenstein R, Koscileniak E, Crown J, Dazzi C, Cariello A, Marangolo M.

Crit Rev Oncol Hematol. 2002 Feb;41(2):129-40. Review.

PMID:
11856589
41.

Neoadjuvant high dose chemotherapy plus peripheral blood progenitor cells in inflammatory breast cancer: a multicenter phase II pilot study.

Dazzi C, Cariello A, Rosti G, Tienghi A, Molino A, Sabbatini R, Aieta M, Frassineti GL, Vertogen B, Giovanis P, Marangolo M.

Haematologica. 2001 May;86(5):523-9.

42.

Amifostine (Ethyol) as modulator of hepatic and biliary toxicity from intraarterial hepatic chemoembolization: results of a phase I study.

Fiorentini G, Giovanis P, Leoni M, De Giorgi U, Cariello A, Dazzi C, Caldeo A.

Hepatogastroenterology. 2001 Mar-Apr;48(38):313-6.

PMID:
11379297
43.

Locoregional therapy for liver metastases from colorectal cancer: the possibilities of intraarterial chemotherapy, and new hepatic-directed modalities.

Fiorentini G, Poddie DB, Cantore M, Giovanis P, Guadagni S, De Giorgi U, Cariello A, Dazzi C, Turci D.

Hepatogastroenterology. 2001 Mar-Apr;48(38):305-12. Review.

PMID:
11379296
44.

Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin's Lymphoma?

Dazzi C, Cariello A, Rosti G, Argnani M, Sebastiani L, Ferrari E, Zornetta L, Monti G, Nicoletti P, Baioni M, Salvucci M, Scarpi E, Marangolo M.

Leuk Lymphoma. 2000 Oct;39(3-4):301-10.

PMID:
11342310
45.

New high-performance liquid chromatographic method for the detection of picolinic acid in biological fluids.

Dazzi C, Candiano G, Massazza S, Ponzetto A, Varesio L.

J Chromatogr B Biomed Sci Appl. 2001 Feb 10;751(1):61-8.

PMID:
11232856
46.

Global approach to hepatic metastases from colorectal cancer: indication and outcome of intra-arterial chemotherapy and other hepatic-directed treatments.

Fiorentini G, Poddie DB, De Giorgi U, Guglielminetti D, Giovanis P, Leoni M, Latino W, Dazzi C, Cariello A, Turci D, Marangolo M.

Med Oncol. 2000 Aug;17(3):163-73. Review.

PMID:
10962525
47.

A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study.

Dazzi C, Cariello A, Giannini M, Del Duca M, Giovanis P, Fiorentini G, Leoni M, Rosti G, Turci D, Tienghi A, Vertogen B, Zumaglini F, De Giorgi U, Marangolo M.

Anticancer Res. 2000 Jan-Feb;20(1B):515-8.

PMID:
10769716
48.

Relationships between total CD34+ cells reinfused, CD34+ subsets and engraftment kinetics in breast cancer patients.

Dazzi C, Cariello A, Rosti G, Monti G, Baioni M, Zornetta L, Ferrari E, Scarpi E, Fiorentini G, Marangolo M.

Haematologica. 2000 Apr;85(4):396-402.

49.

Treatment of small cell lung cancer.

Rosti G, De Giorgi U, Giovanis P, Cariello A, Dazzi C, Marangolo M.

Monaldi Arch Chest Dis. 1999 Oct;54(5):427-34. Review.

PMID:
10741104
50.

Prognostic and predictive value of intratumoral microvessels density in operable non-small-cell lung cancer.

Dazzi C, Cariello A, Maioli P, Solaini L, Scarpi E, Rosti G, Lanzanova G, Marangolo M.

Lung Cancer. 1999 May;24(2):81-8.

PMID:
10444058

Supplemental Content

Support Center